SCHEMBL19187519

SCHEMBL19187519

O=[SH](=O)Nc1cccc2cc[nH]c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 1/20 0.56
▸ PGR P06401 1/20 0.56
▸ NR3C2 P08235 1/20 0.56
▸ AR P10275 1/20 0.56
▸ AHR P35869 1/20 0.46
▸ KEAP1 Q14145 1/20 0.44
▸ PDPK1 O15530 1/20 0.43
▸ BACE1 P56817 1/20 0.41
▸ BCHE P06276 3/20 0.41
▸ TRPV1 Q8NER1 1/20 0.39
▸ EGFR P00533 1/20 0.38
▸ GRM5 P41594 1/20 0.36
▸ ATR Q13535 1/20 0.36
▸ PTPN11 Q06124 1/20 0.36
▸ ACLY P53396 1/20 0.35
▸ PTPRC P08575 1/20 0.34
▸ PTPN2 P17706 1/20 0.34
▸ PTPN1 P18031 1/20 0.34
▸ PTPRB P23467 1/20 0.34
▸ PTPRE P23469 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13085560 0.75 NR3C1 (0.61) NR3C1PGRNR3C2ARAHR
SCHEMBL2161116 0.71 NR3C1 (1.00) NR3C1PGRNR3C2ARAHR
SCHEMBL5497010 0.71 PDPK1 (0.57) NR3C1PGRNR3C2ARAHR
SCHEMBL6091339 0.71 NR3C1 (0.57) NR3C1PGRNR3C2ARKEAP1
SCHEMBL30026274 0.71 PDPK1 (0.57) NR3C1PGRNR3C2ARAHR
SCHEMBL31456523 0.71 NR3C1 (0.57) NR3C1PGRNR3C2ARKEAP1
SCHEMBL28940859 0.70 NR3C1 (0.51) NR3C1PGRNR3C2ARAHR
SCHEMBL21779263 0.70 NR3C1 (0.60) NR3C1PGRNR3C2ARAHR
SCHEMBL22001247 0.70 NR3C1 (0.56) NR3C1PGRNR3C2ARAHR
SCHEMBL31668711 0.69 TRPV1 (0.65) NR3C1PGRNR3C2ARKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2509600-B1 THERAPEUTICALLY ACTIVE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER CHARACTERIZED AS HAVING AN IDH MUTATION AGIOS PHARMACEUTICALS INC (US) 2017-08-02 — — EP disclosed
Send feedback